Regulation of ovarian function: The role of anti-Müllerian hormone

Reproduction

Volumn 124, Issue 5, 2002, Pages 601-609

  Durlinger, Alexandra L L ^a   Visser, Jenny A ^a   Themmen, Axel P N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GROWTH FACTOR; MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; CONTROLLED STUDY; FEMALE; HORMONE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUELLERIAN DUCT; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; REVIEW; SEXUAL DEVELOPMENT;

ANIMALIA; FALLOPIA;

EID: 0036856434     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.0.1240601     Document Type: Review

References (70)

1. Baarends WM, van Helmond MJ, Post M et al. (1994) A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct Development 120 189-197
2. Baarends WM, Uilenbroek IT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP and Grootegoed JA (1995) Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle and gonadotropin-induced follicle growth Endocrinology 136 4951-4962
3. Behringer RR, Cate RL, Froelick GJ, Palmiter RD and Brinster RL (1990) Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance Nature 345 167-170
4. Behringer RR, Finegold MJ and Cate RL (1994) Müllerian-inhibiting substance function during mammalian sexual development Cell 79 415-425
5. Brown JB (1978) Pituitary control of ovarian function: concepts derived from gonadotrophin therapy Australian and New Zealand Journal of Obstetrics and Gynaecology 18 46-54
6. Cate RL, Mattaliano RJ, Hession C et al. (1986) Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells Cell 45 685-698
7. Chin TW, Parry RL and Donahoe PK (1991) Human Müllerian inhibiting substance inhibits tumor growth in vitro and in vivo. Cancer Research 51 2101-2106
8. Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM and Donahoe PK (2001) Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression Molecular Endocrinology 15 946-959
9. de Vet A, Laven JS, de Jong FH, Themmen AP and Fauser BC (2002) Anti-Müllerian hormone serum levels: a putative marker for ovarian aging Fertility and Sterility 77 357-362
10. Dewulf N, Verschueren K, Lonnoy O, Moren A, Grimsby S, Vande Spiegle K, Miyazono K, Huylebroeck D and Ten Dijke P (1995) Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis Endocrinology 136 2652-2663
11. di Clemente N, Goxe B, Rémy JJ, Cate RL, Josso N, Vigier B and Salesse R (1994a) Inhibitory effect of AMH upon the expression of aromatase activity and LH receptors by cultured granulosa cells of rat and porcine immature ovaries Endocrine 2 553-558
12. di Clemente N, Wilson C, Faure E et al. (1994b) Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone Molecular Endocrinology 8 1006-1020
13. Dissen GA, Romero C, Hirshfield AN and Ojeda SR (2001) Nerve growth factor is required for early follicular development in the mammalian ovary Endocrinology 142 2078-2086
14. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N and Matzuk MM (1996) Growth differentiation factor-9 is required during early ovarian folliculogenesis Nature 383 531-535
15. Durlinger AL (2000) Ovarian Follicle Growth and Development: Role of Anti-Müllerian Hormone PhD Thesis, Erasmus University, Rotterdam
16. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA and Themmen AP (1999) Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary Endocrinology 140 5789-5796
17. Durlinger AL, Gruijters MJ, Kramer P et al. (2001) Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary Endocrinology 142 4891-4899
18. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA and Themmen AP (2002) Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary Endocrinology 143 1076-1084
19. Elvin JA, Clark AT, Wang P, Wolfman NM and Matzuk MM (1999a) Paracrine actions of growth differentiation factor-9 in the mammalian ovary Molecular Endocrinology 13 1035-1048
20. Elvin JA, Yan C, Wang P, Nishimori K and Matzuk MM (1999b) Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary Molecular Endocrinology 13 1018-1034
21. Fuller AF, Jr, Krane IM, Budzik GP and Donahoe PK (1985) Müllerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay Gynecologic Oncology 22 135-148
22. Gouedard L, Chen YG, Thevenet L, Racine C, Borie S, Lamarre I, Josso N, Massagué J and di Clemente N (2000) Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor Journal of Biological Chemistry 275 27 973-27 978
23. Gustafson ML, Lee MM, Scully RE et al. (1992) Müllerian inhibiting substance as a marker for ovarian sex-cord tumor New England Journal of Medicine 326 466-471
24. Ha TU, Segev DL, Barbie D et al. (2000) Müllerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism Journal of Biological Chemistry 275 37 101-37 109
25. Halpin DM and Chariton HM (1988) Effects of short-term injection of gonadotrophins on ovarian follicle development in hypogonadal (hpg) mice Journal of Reproduction and Fertility 82 393-400
26. Hayashi M, McGee EA, Min G, Klein C, Rose UM, van Duin M and Hsueh AJ (1999) Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles Endocrinology 140 1236-1244
27. Hirobe S, He WW, Lee MM and Donahoe PK (1992) Müllerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity Endocrinology 131 854-862
28. Hirobe S, He WW, Gustafson ML, MacLaughlin DT and Donahoe PK (1994) Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or Graafian follicle selection Biology and Reproduction 50 1238-1243
29. Hirshfield AN and De Paolo LV (1981) Effect of suppression of the surge of follicle-stimulating hormone with porcine follicular fluid on follicular development in the rat Journal of Endocrinology 88 67-71
30. Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, di Clemente N, Josso N and Picard JY (1996) A 27 base-pair deletion of the anti-Müllerian hormone type II receptor gene is the most common cause of the persistent Müllerian duct syndrome Human Molecular Genetics 5 1269-1277
31. Ingraham HA, Hirokawa Y, Roberts LM, Mellon SH, McGee E, Nachtigal MW and Visser JA (2000) Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction Recent Progress in Hormone Research 55 53-67; discussion 67-68
32. Josso N, Picard JY, Imbeaud S, di Clemente N and Rey R (1997) Clinical aspects and molecular genetics of the persistent Müllerian duct syndrome Clinical Endocrinology 47 137-144
33. Jost A (1947) Reserches sur la differenciation sexuelle de l'embryon de lapin Archives d'Anatomie Microscopique et de Morphologie Expérimentale 36 271-315
34. Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA and Richards CJ (1992) The inhibitory effects of Müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells Journal of Clinical Endocrinology and Metabolism 75 911-917
35. Kumar TR, Wang Y, Lu N and Matzuk MM (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility Nature Genetics 15 201-204
36. Lane AH, Lee MM, Fuller AF, Jr, Kehas DJ, Donahoe PK and MacLaughlin DT (1999) Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors Gynecologic Oncology 73 51-55
37. Lee MM, Donahoe PK, Hasegawa T et al. (1996) Müllerian inhibiting substance in humans: normal levels from infancy to adulthood Journal of Clinical Endocrinology and Metabolism 81 571-576
38. Long WQ, Ranchin V, Pautier P et al. (2000) Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay Journal of Clinical Endocrinology and Metabolism 85 540-544
39. McGee EA and Hsueh AJ (2000) Initial and cyclic recruitment of ovarian follicles Endocrine Reviews 21 200-214
40. McGee EA, Perlas E, LaPolt PS, Tsafriri A and Hsueh AJ (1997) Follicle-stimulating hormone enhances the development of preantral follicles in juvenile rats Biology of Reproduction 57 990-998
41. McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H and Hsueh AJ (2001) Müllerian inhibitory substance induces growth of rat preantral ovarian follicles Biology of Reproduction 64 293-298
42. Masiakos PT, MacLaughlin DT, Maheswaran S et al. (1999) Human ovarian cancer, cell lines, and primary ascites cells express the human Müllerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS Clinical Cancer Research 5 3488-3499
43. Massagué J (1990) The transforming growth factor-β family Annual Review of Cell Biology 6 597-641
44. Massagué J and Chen YG (2000) Controlling TGF-β signaling Genes and Development 14 627-644
45. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL and Behringer RR (1996) Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation Genes and Development 10 2577-2587
46. Munsterberg A and Lovell-Badge R (1991) Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation Development 113 613-624
47. Nakao A, Imamura T, Souchelnytskyi S et al. (1997) TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4 EMBO Journal 16 5353-5362
48. Nilsson E, Parrott JA and Skinner MK (2001) Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis Molecular and Cellular Endocrinology 175 123-130
49. Parrott JA and Skinner MK (1997) Direct actions of kit-ligand on theca cell growth and differentiation during follicle development Endocrinology 138 3819-3827
50. Parrott JA and Skinner MK (1999) Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis Endocrinology 140 4262-4271
51. Parry RL, Chin TW, Epstein J, Hudson PL, Powell DM and Donahoe PK (1992) Recombinant human Müllerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo. Cancer Research 52 1182-1186
52. Perez GI, Robles R, Knudson CM, Flaws JA, Korsmeyer SJ and Tilly JL (1999) Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency Nature Genetics 21 200-203
53. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL and Skakkebaek NE (1999) Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells Journal of Clinical Endocrinology and Metabolism 84 3836-3844
54. Rey RA, Lhommé C, Marcillac I, Lahlou N, Duvillard P, Josso, N and Bidart JM (1996) Anti-Müllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol American Journal of Obstetrics and Gynecology 174 958-965
55. Rey R, Sabourin JC, Venara M, Long WQ Jaubert F, Zeller WP, Duvillard P, Chemes H and Bidart JM (2000) Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors Human Pathology 31 1202-1208
56. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW and te Velde ER (1999) Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility Fertility and Sterility 72 845-851
57. Scully RE (1995) Pathology of ovarian cancer precursors Journal of Cellular Biochemistry Supplement 23 208-218
58. Seifer DB, MacLaughlin DT, Christian BP, Feng B and Shelden RM (2002) Early follicular serum Müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertility and Sterility 77 468-471
59. Silverman LA and Gitelman SE (1996) Immunoreactive inhibin, Müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors Journal of Pediatrics 129 918-921
60. Stephen AE, Masiakos PT, Segev DL, Vacanti JP, Donahoe PK and MacLaughlin DT (2001) Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo. Proceedings National Academy of Sciences USA 98 3214-3219
61. Takahashi M, Koide SS and Donahoe PK (1986) Müllerian inhibiting substance as oocyte meiosis inhibitor Molecular and Cellular Endocrinology 47 225-234
62. Taketo T, Saeed J, Manganaro T, Takahashi M and Donahoe PK (1993) Müllerian inhibiting substance production associated with loss of oocytes and testicular differentiation in the transplanted mouse XX gonadal primordium Biology of Reproduction 49 13-23
63. Teixeira J, Saeed J, Manganaro T, Takahashi M and Donahoe PK (2001) Müllerian inhibiting substance: an instructive development hormone with diagnostic and possible therapeutic applications Endocrine Reviews 22 657-674
64. Tsafriri A, Picard JY and Josso N Immunopurified anti-Müllerian hormone does not inhibit spontaneous resumption of meiosis in vitro of rat oocytes Biology of Reproduction 38 481-485
65. Ueno S, Kuroda T, Maclaughlin DT, Ragin RC, Manganaro TF and Donahoe PK (1989) Müllerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle Endocrinology 125 1060-1066
66. van Cappellen WA, Meijs-Roelofs HM, Kramer P and Van den Dungen HM (1989) Ovarian follicle dynamics in immature rats treated with a luteinizing hormone-releasing hormone antagonist (Org. 30276) Biology of Reproduction 40 1247-1256
67. van Cappellen WA, Osman P and Meijs-Roelofs HM (1993) Model of antral follicle dynamics during the 5-day cycle in rats based on measurement of antral follicle inflow Journal of Reproduction and Fertility 99 57-63
68. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP and Ingraham HA (2001) The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling Molecular Endocrinology 15 936-945
69. Vitt UA, McGee EA, Hayashi M and Hsueh AJ (2000) In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats Endocrinology 141 3814-3820
70. Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK and Lyons KM (2001) The type 1 BMP receptor BmprIB is essential for female reproductive function Proceedings National Academy of Sciences USA 98 7994-7999